175 related articles for article (PubMed ID: 36967828)
1. Protective effects of intrathecal injection of AAV9-RabGGTB-GFP
Gao T; Huo J; Xin C; Yang J; Liu Q; Dong H; Li R; Liu Y
Front Aging Neurosci; 2023; 15():1092607. PubMed ID: 36967828
[TBL] [Abstract][Full Text] [Related]
2. Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.
Yang J; Xin C; Huo J; Li X; Dong H; Liu Q; Li R; Liu Y
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002490
[TBL] [Abstract][Full Text] [Related]
3. RABGGTB plays a critical role in ALS pathogenesis.
Ma H; Huo J; Xin C; Yang J; Liu Q; Dong H; Li R; Liu Y
Brain Res Bull; 2024 Jan; 206():110833. PubMed ID: 38042502
[TBL] [Abstract][Full Text] [Related]
4. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
5. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
7. P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1
Bartlett R; Sluyter V; Watson D; Sluyter R; Yerbury JJ
PeerJ; 2017; 5():e3064. PubMed ID: 28265522
[TBL] [Abstract][Full Text] [Related]
8. Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Medelin M; Rancic V; Cellot G; Laishram J; Veeraraghavan P; Rossi C; Muzio L; Sivilotti L; Ballerini L
J Physiol; 2016 Jul; 594(13):3827-40. PubMed ID: 27098371
[TBL] [Abstract][Full Text] [Related]
9. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
10. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
11. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
12. Implication of 5-HT in the Dysregulation of Chloride Homeostasis in Prenatal Spinal Motoneurons from the G93A Mouse Model of Amyotrophic Lateral Sclerosis.
Martin E; Cazenave W; Allain AE; Cattaert D; Branchereau P
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046135
[TBL] [Abstract][Full Text] [Related]
13. Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Giusto E; Codrich M; de Leo G; Francardo V; Coradazzi M; Parenti R; Gulisano M; Vicario N; Gulino R; Leanza G
J Comp Neurol; 2020 Feb; 528(2):231-243. PubMed ID: 31364764
[TBL] [Abstract][Full Text] [Related]
14. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang Q; Martin LJ
J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
[TBL] [Abstract][Full Text] [Related]
15. Early upregulation of cytosolic phospholipase A
Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R
J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547
[TBL] [Abstract][Full Text] [Related]
16. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
17. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.
Chang Q; Martin LJ
Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771
[TBL] [Abstract][Full Text] [Related]
18. Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1
Valbuena GN; Cantoni L; Tortarolo M; Bendotti C; Keun HC
Front Neurosci; 2019; 13():1276. PubMed ID: 31920474
[TBL] [Abstract][Full Text] [Related]
19. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
20. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
